Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person12
Humacyte, Inc.
Company
HUMANA INC
Company
VERACYTE, INC.
Company
Vaxcyte, Inc.
Company
MAXCYTE, INC.
Company
HUYA Inc.
Company
HP INC
Company
PharmaCyte Biotech, Inc.
Company
Macy's, Inc.
Company
INCYTE CORP
Company
HUBSPOT INC
Company
HUBBELL INC
Company
Primary record9
Humacyte, Inc. filed 4
SEC form 4 filed by Humacyte, Inc. (CIK 1818382) on 2026-10-07.
Humacyte, Inc. filed 4
SEC form 4 filed by Humacyte, Inc. (CIK 1818382) on 2026-10-07.
Humacyte, Inc. filed 8-K
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 22, 2026, the Board of Directors (the Board ) of
Humacyte, Inc. filed 4
SEC form 4 filed by Humacyte, Inc. (CIK 1818382) on 2026-09-15.
Humacyte, Inc. filed 25-NSE
0001354457-26-000819.txt : 20260825 25-NSE 1 primary_doc.xml X0203 0001354457 Nasdaq Stock Market LLC 0001818382 Humacyte, Inc. 001-39532 2525 East North Carolina Highway 54 Durham NC NORTH CAROLINA 27713 (919) 313-9633
Humacyte, Inc. filed 4
SEC form 4 filed by Humacyte, Inc. (CIK 1818382) on 2026-08-21.
Humacyte, Inc. filed 4
SEC form 4 filed by Humacyte, Inc. (CIK 1818382) on 2026-08-19.
Humacyte, Inc. filed SCHEDULE 13D/A
0001104659-26-098152.txt : 20260818 SCHEDULE 13D/A 1 primary_doc.xml X0202 SCHEDULE 13D/A 0001104659-21-112194 0000042872 XXXXXXXX LIVE 11 Common Stock, par value $0.0001 per share 08/14/2026 false 0001818382 020751103 H
Humacyte, Inc. filed 8-K
Item 2.02. Results of Operations and Financial Condition On August 12, 2026, Humacyte, Inc. issued a press release regarding its financial results for its fiscal second quarter ended June 30, 2026. A copy of this press r